Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway

Journal of Cellular Biochemistry

Volumn 94, Issue 6, 2005, Pages 1218-1233

  Al Shami, Rania ^a   Sorensen, Esben S ^b   Ek Rylander, Barbro ^c   Andersson, Göran ^c   Carson, Daniel D ^a   Farach Carson, Mary C ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Migration; Osteopontin; p70 S6 kinase; Tartrate resistant acid phosphatase; Trophoblast; Uteroferrin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; GLYCOPROTEIN; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P70; RAPAMYCIN; S6 KINASE; TARTARIC ACID;

ACTIN FILAMENT; ARTICLE; BREAST MILK; CELL MIGRATION; CHORIOCARCINOMA; CONTROLLED STUDY; DEPHOSPHORYLATION; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; NIDATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TROPHOBLAST; UTERUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; CELL LINE, TUMOR; CHORIOCARCINOMA; CHROMONES; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; ISOELECTRIC FOCUSING; MORPHOLINES; OSTEOPONTIN; PHOSPHORYLATION; PROTEIN KINASES; RIBOSOMAL PROTEIN S6 KINASES; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 23944445440     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20379     Document Type: Article

References (62)

1. Alessi DR, Kozlowski MT, Weng QP, Morrice N, Avruch J. 1998. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol 8:69-81.
2. Andersson G, Ek-Rylander B, Hollberg K, Ljusberg-Sjolander J, Lang P, Norgard M, Wang Y, Zhang SJ. 2003. TRACP as an osteopontin phosphatase. J Bone Miner Res 18:1912-1915.
3. Apparao KB, Illera MJ, Beyler SA, Olson GE, Osteen KG, Corjay MH, Boggess K, Lessey BA. 2003. Regulated expression of osteopontin in the peri-implantation rabbit uterus. Biol Reprod 68:1484-1490.
4. Balasubramanian S, Kuppuswamy D. 2003. RGD-containing peptides activate S6K1 through beta3 integrin in adult cardiac muscle cells. J Biol Chem 278:42214-42224.
5. Bayless KJ, Davis GE, Meininger GA. 1997. Isolation and biological properties of osteopontin from bovine milk. Protein Expr Purif 9:309-314.
6. Berven LA, Willard FS, Crouch MF. 2004. Role of the p70(S6K) pathway in regulating the actin cytoskeleton and cell migration. Exp Cell Res 296:183-195.
7. Chakraborty C, Gleeson LM, McKinnon T, Lala PK. 2002. Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol 80:116-124.
8. Chellaiah M, Kizer N, Silva M, Alvarez U, Kwiatkowski D, Hruska KA. 2000. Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol 148:665-678.
9. Chellaiah MA, Soga N, Swanson S, McAllister S, Alvarez U, Wang D, Dowdy SF, Hruska KA. 2000. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 275:11993-12002.
10. Chen RH, Chung J, Blenis J. 1991. Regulation of pp90rsk phosphorylation and S6 phosphotransferase activity in Swiss 3T3 cells by growth factor-, phorbol ester-, and cyclic AMP-mediated signal transduction. Mol Cell Biol 11:1861-1867.
11. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF, Yeatman TJ. 2004. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 10:184-190.
12. Dennis PB, Pullen N, Kozma SC, Thomas G. 1996. The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol Cell Biol 16:6242-6251.
13. Dennis PB, Pullen N, Pearson RB, Kozma SC, Thomas G. 1998. Phosphorylation sites in the autoinhibitory domain participate in p70(s6k) activation loop phosphorylation. J Biol Chem 273:14845-14852.
14. Duong LT, Lakkakorpi P, Nakamura I, Rodan GA. 2000. Integrins and signaling in osteoclast function. Matrix Biol 19:97-105.
15. Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G. 1994. Dephosphoiylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269:14853-14856.
16. Funhoff EG, Ljusberg J, Wang Y, Andersson G, Averill BA. 2001. Mutational analysis of the interaction between active site residues and the loop region in mammalian purple acid phosphatases. Biochemistry 40:11614-11622.
17. Furger KA, Menon RK, Tuckl AB, Bramwelll VH, Chambers AF. 2001. The functional and clinical roles of osteopontin in Cancer and metastasis. Curr Mol Med 1:621-632.
18. Gang X, Ueki K, Ron S, Maeda M, Naruse T, Nojima Y. 2001. Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy. Am J Kidney Dis 37:374-379.
19. Ganguly S, Ghosh JJ. 1978. Studies on phosphatases of human endometrium: Physiological significance of tissue specific acid phosphatase isoenzymes. Indian J Biochem Biophys 15:363-368.
20. Garlow JE, Ka H, Johnson GA, Burghardt RC, Jaeger LA, Bazer FW. 2002. Analysis of osteopontin at the maternal-placental interface in pigs. Biol Reprod 66:718-725.
21. Gaumann A, Petrow P, Mentzel T, Mayer E, Dahm M, Otto M, Kirkpatrick CJ, Kriegsmann J. 2001. Osteopontin expression in primary sarcomas of the pulmonary artery. Virchows Arch 439:668-674.
22. Gomez-Cambronero J. 2003. Rapamycin inhibits GM-CSF-induced neutrophil migration. FEBS Lett 550:94-100.
23. Gomez-Cambronero J, Horn J, Paul CC, Baumann MA. 2003. Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: Involvement of the ribosomal p70 S6 kinase signaling pathway. J Immunol 171:6846-6855.
24. Goncharova EA, Ammit AJ, Irani C, Carroll RG, Eszterhas AJ, Panettieri RA, Krymskaya VP. 2002. PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283:L354-L363.
25. Gonzalez BY, Perera OP, Michel FJ, Simmen RC. 1995. Multiple upstream promoter elements of the gene for the pregnancy-associated tartrate-resistant acid phosphatase, uteroferrin bind human endometrial nuclear proteins. Mol Cell Endocrinol 108:51-65.
26. Huang J, Kontos CD. 2002. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Arterioscler Thromb Vasc Biol 22:745-751.
27. Janckila AJ, Yaziji H, Lear SC, Martin AW, Yam LT. 1996. Localization of tartrate-resistant acid phosphatase in human placenta. Histochem J 28:195-200.
28. Johnson GA, Burghardt RC, Bazer FW, Spencer TE. 2003. Osteopontin: Roles in implantation and placentation. Biol Reprod 69:1458-1471.
29. Jono S, Peinado C, Giachelli CM. 2000. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275:20197-20203.
30. Kahan C, Seuwen K, Meloche S, Pouyssegur J. 1992. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition. J Biol Chem 267:13369-13375.
31. Katayama Y, House CM, Udagawa N, Kazama JJ, McFarland RJ, Martin TJ, Findlay DM. 1998. Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts. J Cell Physiol 176:179-187.
32. Koguchi Y, Kawakami K, Uezu K, Fukushima K, Kon S, Maeda M, Nakamoto A, Owan I, Kuba M, Kudeken N, Azuma M, Yara S, Shinzato T, Higa F, Tateyama M, Kadota J, Mukae H, Kohno S, Uede T, Saito A. 2003. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am J Respir Crit Care Med 167:1355-1359.
33. Lasa M, Chang PL, Prince CW, Pinna LA. 1997. Phosphorylation of osteopontin by Golgi apparatus casein kinase. Biochem Biophys Res Commun 240:602-605.
34. Lecrone V, Li W, Devoll RE, Logothetis C, Farach-Carson MC. 2000. Calcium signals in prostate cancer cells: Specific activation by bone-matrix proteins. Cell Calcium 27:35-42.
35. Lessey BA. 2002. Adhesion molecules and implantation. J Reprod Immunol 55:101-112.
36. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. 1995. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 95:713-724.
37. Neame PJ, Butler WT. 1996. Posttranslational modification in rat bone osteopontin. Connect Tissue Res 35:145-150.
38. Polakiewicz RD, Schieferl SM, Gingras AC, Sonenberg N, Comb MJ. 1998. mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem 273:23534-23541.
39. Pullen N, Thomas G. 1997. The modular phosphorylation and activation of p70s6k. FEBS Lett 410:78-82.
40. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G. 1998. Phosphorylation and activation of p70s6k by PDK1. Science 279:707-710.
41. Qian Y, Corum L, Meng Q, Blenis J, Zheng JZ, Shi X, Flynn DC, Jiang BH. 2004. PI3K induced actin filament remodeling through Akt and p70S6K1: Implication of essential role in cell migration. Am J Physiol Cell Physiol 286:C153-C163.
42. Razzouk S, Brunn JC, Qin C, Tye CE, Goldberg HA, Butler WT. 2002. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone 30:40-47.
43. Rodan GA. 1995. Osteopontin overview. Ann NY Acad Sci 760:1-5.
44. 2+ influx. J Biol Chem 273:29935-29941.
45. Saitoh M, Pullen N, Brennan P, Cantrell D, Dennis PB, Thomas G. 2002. Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J Biol Chem 277:20104-20112.
46. Salih E, Zhou HY, Glimcher MJ. 1996. Phosphorylation of purified bovine bone sialoprotein and osteopontin by protein kinases. J Biol Chem 271:16897-16905.
47. Sorensen ES, Hojrup P, Petersen TE. 1995. Posttranslational modifications of bovine osteopontin: Identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci 4:2040-2049.
48. Sorensen S, Justesen SJ, Johnsen AH. 2003. Purification and characterization of osteopontin from human milk. Protein Expr Purif 30:238-245.
49. Standal T, Hjorth-Hansen H, Rasmussen T, Dahl IM, Lenhoff S, Brenne AT, Seidel C, Baykov V, Waage A, Borset M, Sundan A, Hjertner O. 2004. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica 89:174-182.
50. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R. 2003. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci USA 100:4766-4771.
51. Sweet LJ, Alcorta DA, Erikson RL. 1990. Two distinct enzymes contribute to biphasic S6 phosphorylation in serum-stimulated chicken embryo fibroblasts. Mol Cell Biol 10:2787-2792.
52. Tuck AB, Chambers AF. 2001. The role of osteopontin in breast cancer: Clinical and experimental studies. J Mammary Gland Biol Neoplasia 6:419-429.
53. van Dijk S, D'Errico JA, Somerman MJ, Farach-Carson MC, Butler WT. 1993. Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment. J Bone Miner Res 8:1499-1506.
54. Weber GF, Ashkar S, Glimcher MJ, Cantor H. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512.
55. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S. 2002. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol 72:752-761.
56. Weintraub AS, Lin X, Itskovich W, Aguinaldo JG, Chaplin WF, Denhardt DT, Fayad ZA. 2004. Prenatal detection of embryo resorption in osteopontin-deficient mice using serial noninvasive magnetic resonance microscopy. Pediatr Res 55:419-424.
57. Weng QP, Kozlowski M, Belham C, Zhang A, Comb MJ, Avruch J. 1998. Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies. J Biol Chem 273:16621-16629.
58. Wu CB, Pan YM, Simizu Y. 1995. Microsomal casein kinase II in endoplasmic reticulum- and Golgi apparatus-rich fractions of ROS 17/2.8 osteoblast-like cells: An enzyme that modifies osteopontin. Calcif Tissue Int 57:285-292.
59. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F. 2001. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60:1645-1657.
60. Yasui T, Fujita K, Hayashi Y, Ueda K, Kon S, Maeda M, Uede T, Kohri K. 1999. Quantification of osteopontin in the urine of healthy and stone-forming men. Urol Res 27:225-230.
61. Yue TL, McKenna PJ, Ohlstein EH, Farach-Carson MC, Butler WT, Johanson K, McDevitt P, Feuerstein GZ, Stadel JM. 1994. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. Exp Cell Res 214:459-464.
62. Zhu XL, Ganss B, Goldberg HA, Sodek J. 2001. Synthesis and processing of bone sialoproteins during de novo bone formation in vitro. Biochem Cell Biol 79:737-746.